EDGEWELL PERSONAL CARE Co (EPC) stock
EPCNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
$28.74−0.41 (-1.41%)
Close on Nov 12, 2026Market cap $1.32BP/E –Yield –
Edgewell Personal Care ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Edgewell Personal Care's ebitda for the twelve months ending Jun 30, 2026 was $100.10M, down 52.5% year over year. For fiscal 2025 it was $185.40M, down 35.5% from the year before. The highest annual figure on record is $337.60M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $185.40M | -35.5% |
| FY2024 | Sep 30, 2024 | $287.30M | -9.8% |
| FY2023 | Sep 30, 2023 | $318.40M | +17.0% |
| FY2022 | Sep 30, 2022 | $272.20M | -16.8% |
| FY2021 | Sep 30, 2021 | $327.00M | +23.5% |
| FY2020 | Sep 30, 2020 | $264.80M | -21.6% |
| FY2019 | Sep 30, 2019 | $337.60M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $43.60M | -35.0% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $37.50M | -47.0% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $2.40M | -92.3% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $16.60M | -60.3% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $67.10M | -35.7% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $70.80M | -23.5% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $31.00M | -36.2% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $41.80M | -44.6% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $104.40M | -4.0% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $92.50M | +15.8% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $48.60M | -10.7% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $75.40M | -7.7% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $108.70M | +50.1% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $79.90M | +23.1% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $54.40M | +2.3% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $81.70M | -4.4% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $72.40M | -21.8% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $64.90M | -23.7% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $53.20M | -16.6% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $85.50M | +32.4% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $92.60M | +43.6% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $85.10M | +11.8% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $63.80M | +7.0% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $64.60M | -50.6% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $64.50M | -53.9% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $76.10M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $59.60M | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $130.90M | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $139.90M | – |
See a number that looks wrong?